Solventum Corp
NYSE:SOLV
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
63.01
85.77
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value of SOLV.
The Intrinsic Value is calculated as the average of DCF and Relative values:
| IE |
|
Smurfit WestRock PLC
NYSE:SW
|
|
| CA |
S
|
South Bow Corp
TSX:SOBO
|
|
| FR |
P
|
Pluxee NV
PAR:PLX
|
|
| IL |
I
|
Isracard Ltd
TASE:ISCD
|
|
| KR |
|
Youngone Holdings Co Ltd
KRX:009970
|
|
| JP |
F
|
Financial Products Group Co Ltd
TSE:7148
|
|
| CN |
R
|
R&G PharmaStudies Co Ltd
SZSE:301333
|
|
| ZA |
S
|
SAB Zenzele Kabili Holdings (RF) Ltd
JSE:SZK
|
|
| SE |
Y
|
Yubico AB
STO:YUBICO
|
|
| IL |
G
|
Generation Capital Ltd
TASE:GNRS
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Solventum Corp.’s reliance on petrochemical-based raw materials makes it vulnerable to supply chain disruptions and price volatility, which could erode margins if the company can’t pass on cost increases to customers.
Solventum Corp.’s proprietary solvent formulation technology enables it to command premium pricing in niche industrial applications, insulating it from lower-cost competitors and supporting strong margins.
Revenue & Expenses Breakdown
Solventum Corp
Balance Sheet Decomposition
Solventum Corp
| Current Assets | 4.4B |
| Cash & Short-Term Investments | 1.6B |
| Receivables | 1.2B |
| Other Current Assets | 1.6B |
| Non-Current Assets | 9.6B |
| PP&E | 1.3B |
| Intangibles | 7.5B |
| Other Non-Current Assets | 747m |
| Current Liabilities | 2.9B |
| Accounts Payable | 669m |
| Accrued Liabilities | 683m |
| Other Current Liabilities | 1.6B |
| Non-Current Liabilities | 6B |
| Long-Term Debt | 5.1B |
| Other Non-Current Liabilities | 912m |
Free Cash Flow Analysis
Solventum Corp
| Free Cash Flow |
Earnings Waterfall
Solventum Corp
|
Revenue
|
8.4B
|
|
Cost of Revenue
|
-3.9B
|
|
Gross Profit
|
4.6B
|
|
Operating Expenses
|
-3.8B
|
|
Operating Income
|
709m
|
|
Other Expenses
|
815m
|
|
Net Income
|
1.5B
|
SOLV Profitability Score
Profitability Due Diligence
Solventum Corp's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Score
Solventum Corp's profitability score is hidden . The higher the profitability score, the more profitable the company is.
SOLV Solvency Score
Solvency Due Diligence
Solventum Corp's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Score
Solventum Corp's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
SOLV Price Targets Summary
Solventum Corp
According to Wall Street analysts, the average 1-year price target for SOLV is 88.84 USD with a low forecast of 72.72 USD and a high forecast of 108.15 USD.
Dividends
Current shareholder yield for SOLV is hidden .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?